DALRADA PORTFOLIO COMPANIES POISED TO ADDRESS CORONAVIRUS, CERVICAL CANCER AND REDUCING CO2 EMISSIONS WORLDWIDE IN Q2, 2020
SAN DIEGO, CA – MARCH 18, 2020 – Amid global business disruption from COVID-19 (coronavirus), Dalrada Financial Corp. (OTC Pink: DFCO) would like to assure its shareholders and the public that the Company’s operations will continue to push through, making continual advances with its ongoing global initiatives. The Company is soon to announce major advances in health and safety – including anti-bacterial, anti-viral and disinfectants – and ongoing renewable energy with heating and cooling that is intended to significantly reduce carbon emissions worldwide.
Brian Bonar, Chief Executive Officer of Dalrada Financial Corp. states, “Dalrada’s investment portfolio features companies that innovate consumer lifestyle and streamline business operations worldwide. We are extremely pleased with the latest achievements that are designed to catalyze consumer and business cost-savings. Advances are currently in areas of disease prevention, renewable energy and technology.”
Dalrada Health’s primary focus is solving world health problems. Its new brand, GlanHealth, is in the process of launching a full line of anti-bacterial, anti-viral and disinfectant products for consumer and commercial use. The GlanHealth product suite is alcohol-free and is laboratory tested to eliminate bacteria and viruses by 99.9% (a coronavirus surrogate was used in the study). A comprehensive announcement is planned in early Q2, 2020 with products including:
- Hand Sanitizer Foam, Wipes and Spray
- Advanced Sanitizing Soap
- All Purpose Advanced Surface Cleaner
- Antimicrobial Wound & Skin Therapy
- Mold and Mildew Sanitizing & Prevention
- Laundry Sanitizing & Deodorant
Dalrada Health’s cervical cancer pre-screening kits are also soon to be released. The Company filed its patent in India and also a provisional patent in the U.S. Dalrada Health’s quality Visual Inspection with Acetic Acid (VIA) kit is designed to be accessible and affordable. Dalrada Health has screened 100 patients in its first study and will soon begin its second clinical study measuring the effectiveness of its VIA kit compared to the standard form of screening. Cervical cancer is the second most common cancer in women worldwide. For details, visit https://DalradaHealth.com.
Dalrada’s portfolio companies, Likido Limited and Dalrada Precision, are focused on sustainable “green” energy and precision parts manufacturing respectively. Based in Scotland, Likido Limited is innovating reductions in carbon (CO2) emissions with heating and cooling units for residential and commercial use. Likido Limited is led by Dalrada’s Chief Engineering Officer, Stuart Cox, who holds nearly three decades of specialized experience in advanced mechanical processing, combustion systems, sustainable and renewable energy, and low carbon manufacturing.
Brian Bonar adds, “Likido Limited’s solution for reducing carbon emissions holds the potential to reduce the world’s carbon footprint by 80%, with mass adoption. This translates to a healthier environment, more comfortable lifestyles and cost-savings for consumers and businesses. We are extremely proud of Likido Limited’s technological advances that will reach the market in 2020.”
Dalrada Precision is a Malaysia-based precision components and parts manufacturer that supplies assembly parts to OEM manufacturers and to Dalrada’s portfolio of industrial companies. Dalrada Precision’s overseas facility presents a significant cost-savings to domestic components and parts sourcing.
Bonar concludes, “Dalrada Financial Corporation is actively generating advances in health, environmental stewardship and technology resulting in cost-savings for consumers and businesses worldwide. We look forward to updating our shareholders and the public on additional details of these achievements very soon.”
About Dalrada Health
A subsidiary of Dalrada Financial Corp., Dalrada Health is focused on solving health problems around the world. The company develops products and services that address the unmet needs of consumers due to accessibility, affordability, or availability. With operations in the U.S., Malaysia, and India, Dalrada Health can reach underserved markets through strong partnerships and the development of efficient supply chains. Dalrada Health is committed to solving universal health problems through improved methodologies resulting in products and services that benefit the global marketplace. For details, visit https://dalradahealth.com.
About Likido Limited
Likido is an international technology company, developing advanced solutions for the harvesting and recycling of energy. Using its novel heat pump systems (patent pending), Likido is revolutionizing the renewable energy sector with the provision of innovative modular process technologies to maximize the capture and reuse of thermal energy for integrated heating and cooling applications. With uses across industrial, commercial and residential sectors Likido seeks to provide cost savings and to minimize carbon emissions across supply chains. Likido’s novel technologies enable the effective recovery and recycling of process energy, mitigating against climate change and enhancing quality of life through the provision of low-carbon heating and cooling systems. For more information, please visit www.likido.net.
About Dalrada Precision
A subsidiary of Dalrada Financial Corp., Dalrada Precision has been focused on solution-based engineering and the customer experience from day one. By continually delivering on its promises, the Company has created trust while building mutually-successful long-term relationships.
Dalrada Precision is a team of highly-trained and committed individuals. The company takes pride in solving the unique challenges of its customers and constantly improves and enhances its machining and manufacturing capabilities, ultimately becoming a key strategic partner of many businesses. For more information, please visit www.dalradaprecision.com.
About Dalrada (DFCO)
Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The Company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, visit www.dalrada.com or call 1-858-283-1253.
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.
# # #